Deciphering OPA1 mutations pathogenicity by combined analysis of human, mouse and yeast cell models
- 1 October 2018
- journal article
- research article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1864 (10) , 3496-3514
Abstract
No abstract availableKeywords
Funding Information
- MIUR (RBFR131WDS-001, RBFR131WDS-002)
- National Institutes of Health (GM110039)
This publication has 50 references indexed in Scilit:
- Eight human OPA1 isoforms, long and short: What are they for?Biochimica et Biophysica Acta (BBA) - Bioenergetics, 2018
- OPA1 processing in cell death and disease – the long and short of itJournal of Cell Science, 2016
- Improved Locus-Specific Database forOPA1Mutations Allows Inclusion of Advanced Clinical DataHuman Mutation, 2014
- Dominant optic atrophyOrphanet Journal of Rare Diseases, 2012
- OPA1-associated disorders: Phenotypes and pathophysiologyThe International Journal of Biochemistry & Cell Biology, 2009
- OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypesBrain, 2007
- OPA1 processing controls mitochondrial fusion and is regulated by mRNA splicing, membrane potential, and Yme1LJournal of Cell Biology, 2007
- The human dynamin‐related protein OPA1 is anchored to the mitochondrial inner membrane facing the inter‐membrane spaceFEBS Letters, 2002
- Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophyNature Genetics, 2000
- OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28Nature Genetics, 2000